Hoth Therapeutics (HOTH)
(Delayed Data from NSDQ)
$0.97 USD
-0.01 (-1.02%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.94 -0.03 (-3.09%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Cash flow Statements
Fiscal Year End for Hoth Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -7.85 | -11.37 | -14.31 | -7.20 | -7.70 |
Depreciation/Amortization & Depletion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | -0.75 | 0.59 | 0.53 | -0.13 | 0.17 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.15 | 1.48 | 1.69 | 1.20 | 2.59 |
Net Cash From Operating Activities | -8.45 | -9.30 | -12.09 | -6.13 | -4.95 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | -0.05 | 0.00 |
Investments | 0.00 | 1.24 | -0.05 | -1.62 | -0.80 |
Other Investing Activities | 0.00 | -0.07 | -0.12 | -0.17 | -0.10 |
Net Cash from Investing Activities | 0.00 | 1.16 | -0.17 | -1.84 | -0.90 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 11.32 | 5.99 | 18.19 | 8.73 | 7.45 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 11.32 | 6.04 | 18.19 | 8.73 | 7.45 |
Effect of Exchange Rate Changes | -0.01 | -0.01 | -0.03 | -0.02 | 0.00 |
Net Change In Cash & Equivalents | 2.87 | -2.10 | 5.91 | 0.74 | 1.61 |
Cash at Beginning of Period | 6.43 | 8.54 | 2.63 | 1.89 | 0.28 |
Cash at End of Period | 9.29 | 6.43 | 8.54 | 2.63 | 1.89 |
Diluted Net EPS | -2.30 | -9.50 | -16.00 | -14.50 | -21.00 |
Fiscal Year End for Hoth Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -3.67 | -2.04 | -7.85 | -6.14 | -4.06 |
Depreciation/Amortization & Depletion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | -0.16 | -0.20 | -0.75 | 0.40 | 0.10 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.52 | 0.51 | 0.15 | 0.37 | 0.21 |
Net Cash From Operating Activities | -3.32 | -1.72 | -8.45 | -5.38 | -3.74 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 3.68 | 0.00 | 11.32 | 11.32 | 8.91 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 3.68 | 0.00 | 11.32 | 11.32 | 8.91 |
Effect of Exchange Rate Changes | 0.00 | -0.01 | -0.01 | -0.54 | -0.06 |
Net Change In Cash & Equivalents | 0.36 | -1.73 | 2.87 | 5.40 | 5.12 |
Cash at Beginning of Period | 9.29 | 9.29 | 6.43 | 6.43 | 6.43 |
Cash at End of Period | 9.65 | 7.56 | 9.29 | 11.83 | 11.54 |
Diluted Net EPS | -0.24 | -0.46 | -0.25 | -0.60 | -0.57 |